Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

To thwart pathogens, researchers in the epidemiology field of infectious disease (ID) prediction are continuously trying to forecast when, where, and how an ID event will occur.

Silicone wristbands could be more convenient option for collecting exposure data.

PNNL computational neuroscientist Rogene Eichler West honored with the International Society for Neuroregulation & Research Joseph and Ann Marie Horvat Distinguished Service Award.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

Diefenderfer, Earth scientist who focuses on coastal ecosystems at PNNL, recently published “Ten Years of Gulf Coast Ecosystem Restoration Projects Since the Deepwater Horizon Oil Spill,” a cover article.

Interns dive into important research that addresses national needs.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

The Department of Homeland Security Science and Technology Virtual First Responder Capitol Hill Showcase highlighted PNNL work in fentanyl detection standards and database libraries.

ICON science is a Department of Energy-developed framework to enhance scientific outcomes via more intentional design of research efforts across all domains of science.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

An analysis of land use in watersheds that supply drinking water to over a hundred United States cities identified a wide range of exposure to potential contamination.

PNNL scientists are taking part in a Department of Energy climate science field campaign in the Rocky Mountains of Colorado.